DK0684951T3 - Silylerede acetylcholinesterase-inhibitorer - Google Patents
Silylerede acetylcholinesterase-inhibitorerInfo
- Publication number
- DK0684951T3 DK0684951T3 DK94908615.1T DK94908615T DK0684951T3 DK 0684951 T3 DK0684951 T3 DK 0684951T3 DK 94908615 T DK94908615 T DK 94908615T DK 0684951 T3 DK0684951 T3 DK 0684951T3
- Authority
- DK
- Denmark
- Prior art keywords
- silylated
- acetylcholinesterase inhibitors
- compounds
- methods
- acetylcholinesterase
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93400385A EP0611769A1 (en) | 1993-02-16 | 1993-02-16 | Silylated acetylcholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0684951T3 true DK0684951T3 (da) | 1997-05-26 |
Family
ID=8214682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94908615.1T DK0684951T3 (da) | 1993-02-16 | 1994-01-25 | Silylerede acetylcholinesterase-inhibitorer |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0611769A1 (da) |
| JP (1) | JP3516955B2 (da) |
| KR (1) | KR100336547B1 (da) |
| CN (1) | CN1043575C (da) |
| AT (1) | ATE152725T1 (da) |
| AU (1) | AU672885B2 (da) |
| CA (1) | CA2154870C (da) |
| DE (1) | DE69403068T2 (da) |
| DK (1) | DK0684951T3 (da) |
| ES (1) | ES2104358T3 (da) |
| FI (1) | FI111461B (da) |
| GR (1) | GR3024151T3 (da) |
| HU (1) | HUT72736A (da) |
| IL (1) | IL108623A0 (da) |
| MX (1) | MX9401175A (da) |
| NO (1) | NO305517B1 (da) |
| NZ (1) | NZ262247A (da) |
| WO (1) | WO1994019356A1 (da) |
| ZA (1) | ZA94925B (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0627400A1 (en) * | 1993-06-04 | 1994-12-07 | Merrell Dow Pharmaceuticals Inc. | Aromatic acetylcholinesterase inhibitors |
| CN100431539C (zh) * | 2004-01-12 | 2008-11-12 | 和泓生物技术（上海）有限公司 | 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用 |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| EP2475428B1 (en) | 2009-09-11 | 2015-07-01 | Probiodrug AG | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| US20110212928A1 (en) | 2010-02-09 | 2011-09-01 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| CN102791704B (zh) | 2010-03-10 | 2015-11-25 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶(qc, ec 2.3.2.5)的杂环抑制剂 |
| EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6899043B2 (ja) | 2015-05-22 | 2021-07-07 | エージンバイオ， インコーポレイテッド | レベチラセタムの持続放出性医薬組成物 |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| CN112047973B (zh) * | 2019-06-06 | 2022-11-18 | 上海科技大学 | 一种大麻素类化合物，其制备方法、组合物和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0403713A1 (en) * | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
-
1993
- 1993-02-16 EP EP93400385A patent/EP0611769A1/en not_active Withdrawn
-
1994
- 1994-01-25 WO PCT/US1994/000720 patent/WO1994019356A1/en active IP Right Grant
- 1994-01-25 AT AT94908615T patent/ATE152725T1/de active
- 1994-01-25 JP JP51897494A patent/JP3516955B2/ja not_active Expired - Fee Related
- 1994-01-25 EP EP94908615A patent/EP0684951B1/en not_active Expired - Lifetime
- 1994-01-25 CN CN94191196A patent/CN1043575C/zh not_active Expired - Fee Related
- 1994-01-25 ES ES94908615T patent/ES2104358T3/es not_active Expired - Lifetime
- 1994-01-25 KR KR1019950703485A patent/KR100336547B1/ko not_active IP Right Cessation
- 1994-01-25 DE DE69403068T patent/DE69403068T2/de not_active Expired - Lifetime
- 1994-01-25 NZ NZ262247A patent/NZ262247A/en unknown
- 1994-01-25 HU HU9502406A patent/HUT72736A/hu unknown
- 1994-01-25 AU AU61641/94A patent/AU672885B2/en not_active Ceased
- 1994-01-25 DK DK94908615.1T patent/DK0684951T3/da active
- 1994-01-25 CA CA002154870A patent/CA2154870C/en not_active Expired - Fee Related
- 1994-02-10 ZA ZA94925A patent/ZA94925B/xx unknown
- 1994-02-11 IL IL10862394A patent/IL108623A0/xx unknown
- 1994-02-15 MX MX9401175A patent/MX9401175A/es not_active Application Discontinuation
-
1995
- 1995-08-15 FI FI953851A patent/FI111461B/fi not_active IP Right Cessation
- 1995-08-15 NO NO953201A patent/NO305517B1/no unknown
-
1997
- 1997-07-16 GR GR970401801T patent/GR3024151T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE152725T1 (de) | 1997-05-15 |
| AU672885B2 (en) | 1996-10-17 |
| DE69403068T2 (de) | 1997-12-11 |
| EP0611769A1 (en) | 1994-08-24 |
| HUT72736A (en) | 1996-05-28 |
| CN1117733A (zh) | 1996-02-28 |
| WO1994019356A1 (en) | 1994-09-01 |
| ZA94925B (en) | 1994-08-25 |
| NO305517B1 (no) | 1999-06-14 |
| NO953201D0 (no) | 1995-08-15 |
| CN1043575C (zh) | 1999-06-09 |
| KR100336547B1 (ko) | 2002-11-02 |
| CA2154870A1 (en) | 1994-09-01 |
| EP0684951A1 (en) | 1995-12-06 |
| FI953851A0 (fi) | 1995-08-15 |
| NZ262247A (en) | 1996-01-26 |
| ES2104358T3 (es) | 1997-10-01 |
| EP0684951B1 (en) | 1997-05-07 |
| JPH08507059A (ja) | 1996-07-30 |
| AU6164194A (en) | 1994-09-14 |
| DE69403068D1 (en) | 1997-06-12 |
| FI953851A (fi) | 1995-08-15 |
| MX9401175A (es) | 1994-08-31 |
| GR3024151T3 (en) | 1997-10-31 |
| KR960701068A (ko) | 1996-02-24 |
| IL108623A0 (en) | 1994-05-30 |
| NO953201L (no) | 1995-08-15 |
| CA2154870C (en) | 1998-10-27 |
| FI111461B (fi) | 2003-07-31 |
| JP3516955B2 (ja) | 2004-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| DK0684951T3 (da) | Silylerede acetylcholinesterase-inhibitorer | |
| DE69427869T2 (de) | Botulinumtoxine zur behandlung von hyperhydrosis | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| ES2106965T3 (es) | Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa. | |
| HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
| FR2720637B1 (fr) | Compositions cosmétiques photoprotectrices à base d'un mélange synergétique de filtres et utilisations. | |
| IN167848B (da) | ||
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| DE69432626D1 (de) | Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen | |
| NO982582L (no) | Fremgangsmaate for behandling av smerte | |
| ITMI930571A1 (it) | Procedimento ed apparecchiatura per l'analisi di composti volatili organici. | |
| ATE140228T1 (de) | Hydroxymethyl-indolizidine und -chinolizidine | |
| DE59305800D1 (de) | Werkzeug zur behandlung von oberflächen von bauteilen | |
| ATE262527T1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo(2.1.5-cd)indolizin-derivate |